Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-018737-21-IT
EUCTR2010-018737-21-IT
Active, not recruiting
Not Applicable

Safety and efficacy of treatment with propranolol in newborns suffering from rethinopathy of the preterm: a pilot study - Propranolol and ROP

AZIENDA OSPEDALIERA MEYER0 sitesApril 7, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRetinopathy of the pretermMedDRA version: 9.1Level: HLGTClassification code 10047060

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Retinopathy of the preterm
Sponsor
AZIENDA OSPEDALIERA MEYER
Status
Active, not recruiting
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 7, 2010
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA MEYER

Eligibility Criteria

Inclusion Criteria

  • •Newborns with gestational age 23\-32 weeks with ROP Stadium 2 Zone II\-III without plus
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Generals: congenital cardiovascolar anormalities, renal failure, cerebral hemorrhages.
  • •Local: ROP of stadium higher than II

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity (PROP-ROP)Retinopathy of prematurity (ROP), the leading cause of blindness in childrenNeonatal DiseasesOther retinal disorders
ISRCTN18523491A. Meyer University Children's Hospital (Italy)44
Recruiting
Phase 3
Investigating the efficacy of oral propranolol in prevention of severe Retinopathy of Prematurity
IRCT20101018004961N12Kermanshah University of Medical Sciences50
Active, not recruiting
Phase 1
Effect of propranolol in the retinal tumours of patients with von Hippel-Lindau disease
EUCTR2014-003671-30-ESALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDA
Completed
Not Applicable
Clinical study of oral propranolol treatment for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangioma
JPRN-UMIN000004453Gifu University Graduate School of Medicine50
Recruiting
Not Applicable
Clinical study of oral propranolol treatment for infantile hemangiomasinfantile hemangiomas
JPRN-UMIN000004604niversity of Tokyo30